Tevogen Bio Holdings Inc. is a biotechnology company focused on developing innovative cell therapies and immunotherapies for the treatment of various diseases, including cancer and viral infections
The company employs advanced technologies to harness the power of the immune system, particularly through the use of genetically modified T cells, with the aim of providing targeted and effective therapeutic solutions. Tevogen is committed to improving patient outcomes by pioneering treatments that address unmet medical needs, while actively engaging in research and development to advance its therapeutic pipeline.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Tevogen Bio Holdings Inc (NASDAQTVGN) shares are trading higher Monday after the company announced an expanded AI collaboration with Microsoft Corp NASDAQ:MSFTNASDAQMSFT)
Tevogen Bio Holdings Inc. (NASDAQTVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday announcement regarding operational updates. Here's what you need to know.
Tevogen Bio Holdings Inc. (NASDAQTVGN) stock is moving higher on Wednesday after the company announced its artificial intelligence effort, Tevogen AI, has joined Microsoft Corporation NASDAQ:MSFTNASDAQMSFT)
evogen Bio projects strong revenue for its oncology pipeline and reports positive phase 1 trial data for its COVID-19 therapy. The company's stock is trading higher amid increased volume.
